Merck & Co., Inc.
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30250% above fair value
$149.52+3.19 (+2.18%)
Close on Oct 30, 2026Market cap $368.89BP/E 119.6Yield 2.19%
Merck Operating Leases by Year
Operating Leases — Weighted-Average Discount Rate (%) (%)
Merck Operating Leases: 3.5% in FY2025, up 0.3 pts from a year earlier.
Latest, FY2025
3.5%
Period ended Dec 31, 2025
Change on a year earlier
+0.3 pts
3.2% in FY2024
History
7 years
Since FY2019
Sources
6
Documents cited below
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-24) ↗
Reported in Form 10-K Note 10 Leases.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Operating Leases — Weighted-Average Discount Rate (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3.5% | +0.3 pts | Form 10-K (filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | 3.2% | -0.1 pts | Form 10-K (filed 2026-02-24) ↗ |
| FY2023 | Dec 31, 2023 | 3.3% | +0.2 pts | Form 10-K (filed 2025-02-25) ↗ |
| FY2022 | Dec 31, 2022 | 3.1% | +0.5 pts | Form 10-K (filed 2024-02-26) ↗ |
| FY2021 | Dec 31, 2021 | 2.6% | -0.2 pts | Form 10-K (filed 2023-02-24) ↗ |
| FY2020 | Dec 31, 2020 | 2.8% | -0.4 pts | Form 10-K (filed 2022-02-25) ↗ |
| FY2019 | Dec 31, 2019 | 3.2% | – | Form 10-K (filed 2021-02-25) ↗ |
Cite this data
StockData. (2026). Merck Operating Leases (%), annual FY2019–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/lease-disc-rate
See every metric in the Merck KPI table. Data updated Oct 26, 2026.